Stem Cell Treatment
Liv Hospital is the first in-hospital GMP standards Regenerative Medicine and Stem Cell Production Center in Turkey.
Stem cells are special cells that make up the organism and have the ability to differentiate into many cell types, renew themselves and multiply throughout the life of the organism. Stem cells, which have the ability to differentiate under appropriate conditions and turn into different cells that form various tissues and organs, are today intensively used in many areas of medicine, tissue engineering and regenerative medicine studies. In order to maintain the unique functions of stem cells, optimum conditions in which the cells can develop must be provided and they must be produced under conditions that will not cause damage or rejection in the organism for use in medical applications.
LivMedCell
At LivMedCell, which is Turkey's first cellular treatment center under hospital conditions and has international Good Manufacturing Practices (GMP) quality standards, cell/stem cell production is carried out with an advanced laboratory infrastructure, state-of-the-art devices and expert staff. Liv Hospital Regenerative Medicine Stem Cell Production Center is the first center in Turkey where stem cell production is carried out at international standards and hospital conditions.
Good Manufacturing Practices for Cellular Products
A harmonious quality management must be established to ensure the production of a consistent and well-characterized product. As with conventional drugs, this quality standard for cellular products considered in the Advanced Therapy Medicinal Products category is determined within the framework of GMP. Thus, it is confirmed that the products produced are produced according to the necessary predefined quality standards and are not contaminated by infectious agents. This process is carried out by constantly checking and reporting the production, quality control, environmental monitoring, transportation, cleaning and disinfection stages carried out by qualified personnel in special facilities established and operated by preparing protocols determined by risk assessments.
As LivMedCell, we aim to produce knowledge in this field through pre-clinical and clinical research, together with our staff of expert scientists who have made significant contributions to universal science in this field in our country and our experienced physicians who believe in the effectiveness of cellular therapy and have applied these treatment protocols. Thus, one of our biggest goals is to reach a structure that uses the information it produces, as well as applying the information produced using the highest level of technology within the framework of universal scientific and ethical rules.
Our Licensed Products
- Fibroblast from skin tissue
- Mesenchymal Stem Cell from Umbilical Cord
- Mesenchymal Stem Cell from Fat Tissue
- Mesenchymal Stem Cell from Cartilage Tissue
- Mesenchymal Stem Cell from Synovial Tissue
- Exosome
- Fat Tissue Derived Stromal Vascular Fraction (SVF)
- Bone Marrow Derived Mononuclear Cell
